
Curemark has announced the appointment of Matthew Heil to the position of chief scientific officer. Currently, Dr Heil is serving …
Conatus Pharmaceuticals has announced the appointment of Daniel Ripley as head of Corporate Development. Ripley will lead the commercialisation strategy …
David Brennan, the former chief executive of AstraZeneca, could receive more than £4million as a payout after being ousted from …

The European Medicines Agency has appointed Emer Cooke as Head of International and European Co-operation. The International and European Co-operation …

GlaxoSmithKline has finally sealed the acquisition of Human Genome Sciences, the company with which it co-markets lupus treatment Benlysta. The …
Communications firm Spink has strengthened its ethical division with three appointments to work on its healthcare portfolio. Account director Martha …

Spanish chemical supplier Ercros SA has been sent a warning letter from the FDA after an inspection picked up a …

A facility operated by Bristol-Myers Squibb in Puerto Rico stands to benefit from a $165 million investment programme that will …
The Fishawack Group of companies has appointed Glenn Wilson (pictured), Sissy Easo-Joseph and Anna Timbrell to client service positions across …
The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …
GlaxoSmithKline and US biopharma firm Theravance have submitted their investigational chronic obstructive pulmonary disease (COPD) drug to regulators in Europe …

GlaxoSmithKline has launched a UK advertising campaign to celebrate the role anti-doping science will play in keeping the Games as …

AstraZeneca and Dr Steven Paul of Weill Cornell Medical College have unveiled a new research alliance that brings four leading …

AstraZeneca is to acquire a portfolio of neuroscience assets from Link Medicine, a private US pharma firm.The deal is the …
A leading health think-tank has criticised what it calls the ‘financial vacuum’ at the heart of the government’s plans for …
This is Part 1 to the ‘Success Factors in Value Communication Design’ series; a set of articles that examine and explain the …
This is the introductory article to the ‘Success Factors in Value Communication Design’ series; a set of articles that examine and explain …

Takeda Pharmaceuticals has appointed Rob Gallo as head of Corporate Communications, Europe and Canada. Since 2010 Gallo has been the …

The first round of appointments to commissioning support service (CSS) managing director posts has been made by the NHS Commissioning …

Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …